BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Reflect Scientific Inc. Releases Second Quarter 2021 Financials

  Reflect Scientific, Inc., a provider of diverse products and services for biotechnology, pharmaceutical, and transportation industries, announced financial results for the second quarter of 2021.

  August 17, 2021

   · 

  2 min read
• Smith+Nephew expands its leading WEREWOLF™ Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand

  Smith+Nephew, the global medical technology business, announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radio-frequency technology to orthopaedic reconstruction surgeons.

  August 17, 2021

   · 

  6 min read
• Business

  Sparrow Pharmaceuticals Expands Executive Leadership With Appointment of Frank Czerwiec, MD as Chief Medical Officer and Jamie MacPherson, PharmD as Vice President of Regulatory Affairs and Quality

  Sparrow Pharmaceuticals today announced the appointment of Frank Czerwiec, MD, PhD as Chief Medical Officer and Jamie MacPherson, PharmD as Vice President of Regulatory Affairs and Quality.

  August 17, 2021

   · 

  2 min read
• Business

  Intrance Medical Systems Names Krai Chatamra, Ph.D., Vice President of Clinical Development

  Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, announced the appointment of Krai Chatamra, Ph.D., to Vice President of Clinical Development.

  August 17, 2021

   · 

  3 min read
• Business

  CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

  CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021.

  August 17, 2021

   · 

  5 min read
• Business

  Alzamend Neuro Announces It Has Contracted With Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer’s Disease in September 2021

  Alzamend Neuro, Inc. today announced that it contracted Altasciences to conduct a six-month Phase I relative bioavailability study for AL001 for dementia related to Alzheimer’s disease in September 2021.

  August 17, 2021

   · 

  5 min read
• Business

  Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update

  Tenax Therapeutics, Inc. today reported financial results for the second quarter of 2021 and provided a business update.

  August 17, 2021

   · 

  9 min read
• BioForest

  Aptevo Therapeutics Announces APVO436 Monotherapy is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

  Aptevo Therapeutics Inc. today announced the publication of a peer-reviewed research article in the prestigious oncology journal Cancers.

  August 17, 2021

   · 

  8 min read
• Business

  Arthrosi Establishes Joint Venture in China to Accelerate Development of Innovative Drug Portfolio

  Arthrosi Therapeutics, Inc. today announced a joint venture in Guangzhou, China with Guangzhou Ruiao Biopharmaceutical Technology Co., Ltd. (“a subsidiary of ApicHope Phamaceutical”) to form Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd.

  August 17, 2021

   · 

  2 min read
• Genetown

  nanoMesh™ LLC (a subsidiary of Exogenesis Corporation) Announces Formation of a Medical Advisory Board

  nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, today announced the formation of a Medical Advisory Board supporting the commercial launch of the nanoMesh™ product line offering to the clinical community.

  August 17, 2021

   · 

  8 min read